Effects of bevacizumab and capecitabine combined with intraperitoneal thermoperfusion chemotherapy on therapeutic effect, immunity and prognosis of gastric cancer patients.

Liu, Kun; Xu, Jing; Chen, Baoyin; Bai, Yunbo; Ma, Zhufang

Liu, Kun; Xu, Jing; Chen, Baoyin; Bai, Yunbo; Ma, Zhufang.

Afiliação

Liu K; Department of Gastroenterology, Hanzhong 3201 Hospital, Hanzhong, China.
Xu J; Department of Gastroenterology, Hanzhong 3201 Hospital, Hanzhong, China.
Chen B; Department of Gastroenterology, Hanzhong 3201 Hospital, Hanzhong, China.
Bai Y; Department of Medical Oncology, Hanzhong 3201 Hospital, Hanzhong, China.
Ma Z; Department of Gastroenterology, Hanzhong 3201 Hospital, Hanzhong, China - 258131576@qq.com.

Minerva Med ; 113(2): 358-359, 2022 04.

Article em En | MEDLINE | ID: mdl-33555164

Assuntos

Neoplasias Colorretais; Neoplasias Gástricas; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Bevacizumab/uso terapêutico; Capecitabina/uso terapêutico; Humanos; Prognóstico; Neoplasias Gástricas/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Colorretais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google